Drug Profile
CLZ 4
Latest Information Update: 28 Jun 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jun 2001 No-Development-Reported for Alzheimer's disease in USA (Unknown route)
- 08 Dec 1998 New profile
- 08 Dec 1998 Preclinical development for Alzheimer's disease in USA (Unknown route)